47%
- Business
Karuna Therapeutics surges 47% after Bristol Myers Squibb declares $14 billion deal
Bristol Myers Squibb on Friday launched it agreed to aquire biopharmaceutical firm Karuna Therapeutics for $14 billion in money, or…
Read More »
By using our website, you consent to the use of cookies and other tracking technologies as described in our privacy policy.
Bristol Myers Squibb on Friday launched it agreed to aquire biopharmaceutical firm Karuna Therapeutics for $14 billion in money, or…
Read More »